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We read with interest the article, "Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation" by Kuramitsu et al, 1 which provides interesting data on the frequency of stent fracture with contemporary drug-eluting stents. However, we believe that some of the terminology used is misleading.
Firstly, we believe the term everolimus-eluting stent as used in this article is inappropriate. Mechanical stent complications such as stent recoil, stent fracture, or longitudinal stent deformation (LSD) are not primarily related to the polymer or drug coating but to the underlying stent design. The authors examined the everolimus-eluting Xience V (Abbott Vascular) and Promus (Boston Scientific) stents. These stent platforms are identical and use the thin-strut cobalt chromium Multilink Vision (Abbott Vascular) stent, with 3 connectors between each ring and an in-phase peak to valley design. The Promus Element and Synergy stents (Boston Scientific) are also coated with everolimus but possess a radically different design to the Multilink Vision platform with an alternative alloy (platinum chromium) and only 2 connectors between each ring, which are aligned in an offset peakpeak formation. Despite also being an everolimus-eluting stent, the Element stent design possesses different mechanical properties to the Multilink Vision, as illustrated in recent bench studies showing large variability in longitudinal strength between contemporary stent platforms, 2 and this may be clinically relevant with regard to LSD. 3, 4 Given the enhanced flexibility of the Element platform (Promus Element), the stent fracture rate may actually be lower than with the Multilink Vision stent (Xience V/Promus) and the results of the current study therefore only apply to Xience V/Promus stents and not to all everolimus-eluting stents.
Secondly, the authors describe 3 cases of stent fracture which they attribute to LSD. One of these cases shown in Figure 4 demonstrates a double stent layer and the authors conclude that LSD was the cause of stent fracture. We would disagree with this conclusion. LSD can be defined as deformation of a stent attributable to force applied in the longitudinal axis after initially successful stent deployment, and usually occurs at the stent edge, although rare cases have been described within the stent body. 4 In this case, there was no evidence of stent deformation at the time of implant and the stent fracture appears to have occurred at a site of marked vessel angulation. We would therefore suggest that the double layer of stent struts detected is the consequence of stent fracture rather than the cause.
This article highlights the crucial importance of stent design and how improving one stent attribute may adversely affect other attributes. Stents with strong longitudinal integrity may have a low risk of LSD but will also have reduced flexibility, and hence deliverability, which may in turn increase the risk of stent fracture.
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